Comparing Coloplast A/S (OTCMKTS:CLPBY) & Treace Medical Concepts (NASDAQ:TMCI)

Treace Medical Concepts (NASDAQ:TMCI) and Coloplast A/S (OTCMKTS:CLPBY) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of current recommendations for Treace Medical Concepts and Coloplast A/S, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	1	1	3	0	2.40
Coloplast A/S	1	1	0	2	2.75

Treace Medical Concepts presently has a consensus price target of $6.17, indicating a potential upside of 21.87%. Given Treace Medical Concepts’ higher possible upside, research analysts plainly believe Treace Medical Concepts is more favorable than Coloplast A/S.

Volatility & Risk

Treace Medical Concepts has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Comparatively, Coloplast A/S has a beta of 0.1, indicating that its share price is 90% less volatile than the S&P 500.

Insider and Institutional Ownership

84.1% of Treace Medical Concepts shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Treace Medical Concepts and Coloplast A/S’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-27.44%	-72.99%	-29.19%
Coloplast A/S	10.57%	42.25%	11.87%

Earnings & Valuation

This table compares Treace Medical Concepts and Coloplast A/S”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$203.35 million	1.63	-$59.00 million	($0.86)	-5.88
Coloplast A/S	$4.50 billion	3.69	$478.04 million	$0.21	35.05

Coloplast A/S has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Coloplast A/S, indicating that it is currently the more affordable of the two stocks.

Summary

Coloplast A/S beats Treace Medical Concepts on 10 of the 15 factors compared between the two stocks.

About Treace Medical Concepts

Treace Medical Concepts, Inc. develops and markets medical devices for foot and ankle surgery, with a focus on treatments for bunions and related deformities. Its products are designed for use by surgeons in correcting and stabilizing bones and joints in the foot. The company’s offerings include the Lapiplasty 3D Bunion Correction System, which uses specialized instruments and fixation implants to support correction of bunion deformities in three dimensions. Treace also sells systems and implants for other foot and ankle procedures, including treatments for deformities involving the midfoot and big toe.

About Coloplast A/S

Coloplast A/S is a Danish medical device company that develops and markets products and services for people with intimate health care needs. Its main business areas include ostomy care, continence care, wound and skin care, and urology care. Its products include ostomy bags and accessories, catheters and other continence products, wound dressings, and devices used in urological procedures. Coloplast also provides voice and respiratory care products, including solutions for people who have had a laryngectomy.